Defining the robustness of zebrafish spinal cord regeneration - primary and secondary tissue damage from spinal cord injury permanently impairs sensory and motor functions, causing irreversible…

Active Project Grant Awarded Last action

Award ID
R21HD116006
Recipient
Awarding agency
Obligated
$495,000

Award facts

Completion date 78% complete
Place of performance
Madison, WI 53715, USA

Award details come from USAspending.gov.

Description

Defining the robustness of zebrafish spinal cord regeneration - primary and secondary tissue damage from spinal cord injury permanently impairs sensory and motor functions, causing irreversible paralysis. Developing therapies to treat and reverse spinal cord injury is an urgent need in regenerative medicine and remains an enormous research challenge. The path to an effective cure is likely to require a combination of molecular, cellular, electrostimulatory, and engineering approaches, and must be guided by a deeper understanding of the inherent regenerative capacity of spinal cord tissue. Following spinal cord injury, nerve cell death and scar formation inhibit regeneration. To date, attempts to alleviate the negative effects of scarring and to support cell survival and nerve regrowth after injury have not overcome the challenges of mammalian spinal cord regeneration. By contrast with mammals, teleost zebrafish can form new neurons, regrow axons, and recover the ability to swim just 6 to 8 weeks after a paralyzing injury that completely severs the spinal cord. Importantly, these regenerative events proceed without massive scarring. Instead, following injury, specialized non-neural glia and other cells build a tissue bridge to connect the two severed ends, allowing axons to grow across the wound and reestablish crucial connections. Encouraging key mammalian cells to adopt this bridging behavior would shift the mammalian spinal cord injury response from scarring to regeneration, potentially to an extent sufficient to save tissue function and restore locomotor function. This highly desirable outcome requires an extensive understanding of the molecular signals that enable or inhibit innate spinal cord regeneration. In preliminary studies, we have generated and bioinformatically assessed datasets of cellular and transcriptome changes that occur in reproducible minority cohorts of zebrafish that retain paralysis after transection injury, with the idea that factors preferentially induced in a failure context could inform barriers to regeneration. We propose to: 1) elucidate cell state changes over time associated with regeneration versus failure after spinal cord injury; and 2) define and manipulate the implicated molecular machinery to reduce the incidence of spontaneous regenerative failure. Our work will provide a new view and understanding of regenerative capacity in the context of spinal cord injury.

Transactions

Action Obligated Date
Amendment $225,000
Original award $270,000

Quick answers

Who received award R21HD116006?

R21HD116006 was awarded to The Morgridge Institute For Research, Inc. by National Institute of Child Health and Human Development (National Institutes of Health) on April 17, 2025.

How much is award R21HD116006 worth?

$495,000 has been obligated on R21HD116006.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award